Averix Bio

ATTN CPhI Attendees: Click here to schedule a get-together in Milan: https://bit.ly/3k67iSR

As surprising as the picture posted below may be to some, IT IS TRUE. Averix Bio has successfully completed a 21 CFR Part 210 and Part 211 compliance audit conducted by the ProPharma Group. That means we now can provide cGMP-compliant API Phytocannabinoid CBD isolate for your research, clinical studies and products. You can trust that Averix is a science-driven manufacturer that minimizes your supply-chain risk and can help you explore the potential benefits of cannabinoid ingredients for patients.

We’re attending the CPhI conference in Milan and would welcome the opportunity to learn more about your company and answer any questions you may have about us, our products or the science supporting the use of cannabinoid ingredients.

Look forward to starting the conversation with you!

The Averix Bio team was excited to participate in the Fourth Annual International Cannabinoid Derived Pharmaceutical (iCDP) Summit last week in Boston. What a spectacular conference! It was truly invigorating to hear from so many researchers and scientists about the rapidly growing interest in exploring the health benefits of cGMP-compliant ingredients.

We especially enjoyed the presentation from Hunter Land, Vice President of Research and Development at Alterola Biotech Inc.: “Carrying Out Translational Studies in Cannabinoid Medicine.” Mr. Land discussed the vital guidelines that researchers must follow to ensure their clinical studies involving cannabinoid ingredients yield accurate, meaningful and safe results. As he noted, Alterola Biotech is focused on “harnessing the therapeutic potential of cannabinoids and cannabinoid-like compounds, which can bring valuable treatments to seriously ill patients.”

Averix Bio couldn’t agree more. As a 21 CFR Part 210 and Part 211 cGMP-compliant supplier of botanical-based API Phytocannabinoid CBD Isolate, we’re ready to be your trusted and transparent partner for your pre-clinical/clinical research and the medical therapies you want to bring to patients in need. Learn more at averixbio.com.